CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13

American Journal of Respiratory Cell and Molecular Biology

Volumn 28, Issue 4, 2003, Pages 420-427

  Price, Kursteen S ^b   Friend, Daniel S ^b   Mellor, Elizabeth A ^b   De Jesus, Nidia ^b   Watts, Gerald F M ^b   Boyce, Joshua A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR4; EOTAXIN; FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; SAPONIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PERMEABILIZATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAST CELL; NOSE POLYP; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SECRETORY GRANULE; UMBILICAL CORD BLOOD;

CELLS, CULTURED; HUMANS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; MAST CELLS; MICROSCOPY, IMMUNOELECTRON; RECEPTORS, CHEMOKINE;

EID: 0345385018     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0155OC     Document Type: Article

References (34)

1. Boyce, J. A., and K. F. Austen. 2001. Biology of the mast cell. In Samter's Immunologic Diseases. K. F. Austen, M. M. Frank, J. P. Atkinson, and H. Cantor, editors. Lippincott, Williams and Wilkins, Inc., Philadelphia, PA. 253-269.
2. Amin, K., J. Rinne, T. Haahtela, M. Simola, C. G. Peterson, G. M. Roomans, H. Malmberg, P. Venge, and L. Seveus. 2001. Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. J. Allergy Clin. Immunol. 107: 249-257.
3. Anderson, D. F., J. D. MacLeod, S. M. Baddeley, A. S. Bacon, J. I. McGill, S. T. Holgate, and W. R. Roche. 1997. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leukocyte infiltration. Clin. Exp. Allergy 27:1060-1066.
4. Laitinen, L. A., A. Laitinen, and T. Haahtela. 1993. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 147:697-704.
5. Pesci, A., A. Foresi, G. Bertorelli, A. Chetta, and D. Oliveri. 1993. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am. Rev. Respir. Dis. 147:684-689.
6. Brightling, C. E., P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346:1699-1705.
7. Bradding, P., Y. Okayama, P. H. Howarth, M. K. Church, and S. T. Holgate. 1995. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155:297-307.
8. Ponath, P. D., S. Qin, T.W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437-2448.
9. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
10. Matthews, A. N., D. S. Friend, N. Zimmermann, M. N. Sarafi, A. D. Luster, E. Pearlman, S. E. Wert, and M. E. Rothenberg. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 95:6273-6278.
11. Humbles, A. A., B. Lu, D. S. Friend, S. Okinaga, J. Lora, A. Al-garawi, T. R. Martin, N. P. Gerard, and C. Gerard. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. USA 99:1479-1484.
12. Gurish, M. F., A. H. Humbles, H. Tao, S. Finkelstein, J. A. Boyce, C. Gerard, D. S. Friend, and K. F. Austen. 2002. CC chemokine receptor (CCR) 3 is required for tissue eosinophilia and larval cytotoxicity after infection with Trichinella spiralis. J. Immunol. 168:5730-5736.
13. Uguccioni, M., C. R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G. I. LaRosa, P. Rao, P. D. Ponath, M. Baggiolini, and C. A. Dahinden. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 100:1137-1143.
14. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005-2007.
15. Ochi, H., W. M. Hirani, Q. Yuan, D. S. Friend, K. F. Austen, and J. A. Boyce. 1999. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190:267-280.
16. Romagnani, P., A. De Paulis, C. Beltrame, F. Annunziato, V. Dente, E. Maggi, S. Romagnani, and G. Marone. 1999. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am. J. Pathol. 155:1195-1204.
17. Toru, H., C. Ra, S. Nonoyama, K. Suzuki, J. Yata, and T. Nakahata. 1996. Induction of the high-affinity IgE receptor (FcεRI) on human mast cells by IL-4. Int. Immunol. 8:1367-1373.
18. Ochi, H., N. H. De Jesus, F. Hsieh, K. F. Austen, and J. A. Boyce. 2000. Interleukins 4 and 5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc. Natl. Acad. Sci. USA 97:10509-10513.
19. Bannert, N., M. Farzan, D. S. Friend, H. Ochi, K. S. Price, J. Sodroski, and J. A. Boyce. 2001. Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro. J. Virol. 75:10808-10814.
20. Nakajima, K., Y. Takei, Y. Tanaka, T. Nakagawa, T. Nakata, Y. Noda, M. Setou, and N. Hirokawa. 2002. Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport. Mol. Cell. Biol. 22:866-873.
21. Lin, T. J., T. B. Issekutz, and J. S. Marshall. 2000. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J. Immunol. 165:211-220.
22. Briken, V., R. M. Jackman, G. F. M. Watts, R. A. Rogers, and S. A. Porcelli. 2000. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J. Exp. Med. 192:281-288.
23. Login, G. R., M. Aoki, M. Yamakawa, L. O. Lunardi, E. C. Digenis, N. Tanda, L. B. Schwartz, and A. M. Dvorak. 1997. Immunocytochemical localization of chymase to cytoplasmic vesicles after rat peritoneal mast cell stimulation by compound 48/80. J. Histochem. Cytochem. 45:1379-1391.
24. Zimmermann, N., J. J. Conkright, and M. E. Rothenberg. 1999. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J. Biol. Chem. 274:12611-12618.
25. Lippert, U., M. Artuc, A. Grutzkau, A. Moller. A. Kenderessy-Szabo, D. Schadendorf, J. Norgauer, K. Hartmann, R. Schweitzer-Stenne, T. Zuberbier, B. M. Henz, and S. Kruger-Krasagakes. 1998. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J. Immunol. 161:2600-2608.
26. Caulfield, J. P., R. A. Lewis, A. Hein, and K. F. Austen. 1980. Secretion in dissociated human pulmonary mast cells: evidence for solubilization of granule contents before discharge. J. Cell Biol. 85:299-312.
27. Burger, K., G. Gimpl, and F. Fahrenholz. 2000. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57:1577-1592.
28. Yamaguchi, M., K. Sayama, K. Yano, C. S. Lantz, N. Noben-Trauth, C. Ra, J. J. Costa, and S. J. Galli. 1999. IgE enhances FcεRI expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell FcεRI expression and mediator release. J. Immunol. 162:5455-5465.
29. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263.
30. Lee, C. G., R. J. Homer, Z. Zhu, S. Lanone, X. Wang, V. Koteliansky, J. M. Shipley, P. Gotwals, P. Noble, Q. Chen, R. M. Senior, and J. A. Elias. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta 1. J. Exp. Med. 194:809-821.
31. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
32. Timmerman, L. A., N. A. Clipstone, S. N. Ho, J. P. Northrop. and G. R. Crabtree. 1996. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 383:837-840.
33. Devouassoux, G., D. D. Metcalfe, and C. Prussin. 1999. Eotaxin potentiates antigen-dependent basophil IL-4 production. J. Immunol. 163:2877-2882.
34. Rothenberg, M. E., A. D. Luster, C. M. Lilly, J. M. Drazen, and P. Leder. 1995. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J. Exp. Med. 181:1211-1216.